Relmada Therapeutics RLMD
NASDAQ RLMD
$4.45 +0.18 (+4.24%)
As of: Nov 11, 2026 · 1:02 PM EST

Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Relmada Therapeutics 455.48 Mn -103.11 Mn - 6.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.62 Mn
Mar 31, 2026 11.37 Mn
Dec 31, 2025 12.26 Mn
Sep 30, 2025 6.29 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 6.27 Mn
Dec 31, 2024 8.08 Mn
Sep 30, 2024 11.86 Mn
Jun 30, 2024 8.10 Mn
Mar 31, 2024 9.68 Mn
Dec 31, 2023 12.08 Mn
Sep 30, 2023 12.24 Mn
Jun 30, 2023 12.29 Mn
Mar 31, 2023 12.29 Mn
Dec 31, 2022 11.83 Mn
Sep 30, 2022 8.21 Mn
Jun 30, 2022 14.60 Mn
Mar 31, 2022 13.28 Mn
Dec 31, 2021 8.91 Mn
Sep 30, 2021 8.66 Mn
API Access

Relmada Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RLMD&period=max&api_key=YOUR_API_KEY